4-(4-Propoxyphenoxy)phenol | 1100179-09-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(4-Propoxyphenoxy)phenol
• CAS: 1100179-09-6
• 化学式: C₁₅H₁₆O₃
• 分子量: 244.29
• InChiKey: FNAGBMSBTIDLJO-UHFFFAOYSA-N

物化性质

• 沸点：
  379.3±27.0 °C(Predicted)
• 密度：
  1.133±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4,4'-二羟基二苯醚 、 溴丙烷 在 氢氧化钾 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 4-(4-Propoxyphenoxy)phenol
  参考文献：
  名称：

  Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives

  摘要：

  The synthesis and biological evaluation of a series of diphenyl ether derivatives were described. The compounds can either activate or inhibit the aminopeptidase activity of leukotriene A(4) hydrolase, while at the same time do not influence the hydrolase activity. Further enzyme kinetics and molecular modeling investigation on these novel chemical activators revealed their possible activation mechanism. These compounds can be used as probes to regulate the aminopeptidase activity of leukotriene A4 hydrolase. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.10.044

文献信息

• 9-MEMBERED FUSED RING DERIVATIVE
  申请人：Shionogi & Co., Ltd.

  公开号：EP3279187A1

  公开（公告）日：2018-02-07

  The purpose of the present invention is to provide novel compounds having ACC2 selective inhibitory activity. In addition, the present invention provides a pharmaceutical composition comprising the compound. A compound of Formula: or its pharmaceutically acceptable salt, wherein, R1 is substituted or unsubstituted fused aromatic heterocyclyl represented by Formula: wherein, ring B is 5-membered ring, ring C is 6-membered ring; ring A is substituted or unsubstituted non-aromatic carbocycle or the like; -L1- is -O-(CR6R7)m- or the like; -L2- is -O-(CR6R7)n- or the like; each R6 is independently hydrogen or the like; each R7 is independently hydrogen or the like; each m is independently an integer of 0, 1, 2 or 3; each n is independently an integer of 1, 2 or 3; R2 is substituted or unsubstituted alkyl; R3 is hydrogen or substituted or unsubstituted alkyl; R4 is substituted or unsubstituted alkylcarbonyl or the like.

  本发明的目的是提供具有 ACC2 选择性抑制活性的新型化合物。此外，本发明还提供了一种包含该化合物的药物组合物。式的化合物： 或其药学上可接受的盐、 其中，R1 是由式表示的取代或未取代的融合芳香杂环基： 其中 环 B 是 5 元环，环 C 是 6 元环； 环 A 是取代或未取代的非芳香族碳环或类似物； -L1-是-O-(CR6R7)m-或类似物； -L2-是-O-(CR6R7)n-或类似物； 每个 R6 独立地为氢或类似物 每个 R7 独立地为氢或类似物； 每个 m 独立地为 0、1、2 或 3 的整数 每个 n 独立地为 1、2 或 3 的整数； R2 是取代或未取代的烷基； R3 是氢或取代或未取代的烷基； R4 是取代或未取代的烷基羰基或类似物。
• Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives
  作者：Xiaolu Jiang、Lu Zhou、Dengguo Wei、Hu Meng、Ying Liu、Luhua Lai

  DOI：10.1016/j.bmcl.2008.10.044

  日期：2008.12

  The synthesis and biological evaluation of a series of diphenyl ether derivatives were described. The compounds can either activate or inhibit the aminopeptidase activity of leukotriene A(4) hydrolase, while at the same time do not influence the hydrolase activity. Further enzyme kinetics and molecular modeling investigation on these novel chemical activators revealed their possible activation mechanism. These compounds can be used as probes to regulate the aminopeptidase activity of leukotriene A4 hydrolase. (C) 2008 Elsevier Ltd. All rights reserved.